From: Time interval between alfentanil and rocuronium administration necessary to prevent rocuronium-induced withdrawal movement
Male(n = 33)
Female(n = 31)
MAP (mmHg)
T0
100.5 ± 11.7
98.0 ± 8.8
T1
85.8 ± 8.2#
82.0 ± 10.9#
T2
80.6 ± 9.6#
81.1 ± 11.1#
HR (beat/min)
73.3 ± 13.9
74.8 ± 11.2
65.8 ± 10.8#
66.3 ± 11.3#
62.6 ± 10.8#
62.3 ± 8.7#